GPT-Rosalind is OpenAI's first domain-specific model, built for drug discovery and life sciences—and it's not for everyone.
Three top OpenAI executives have left as the company reshuffles priorities, with reports also raising questions over Sam ...
Kevin Weil, Bill Peebles, and Srinivas Narayanan leave OpenAI as the company shuts down Sora and dismantles OpenAI for ...
OpenAI is framing GPT-Rosalind as a tool to compress the timeline from scientific idea to clinical evidence. The company ...
This major update marks a significant shift for OpenAI, as it positions the Codex desktop app not just as a chatbot but as a ...
OpenAI executive Srinivas Narayanan, an IIT Madras alumnus who helped scale ChatGPT and API products, has announced his exit ...
By Juby Babu April 16 - OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge ...
OpenAI is seeing a wave of high-profile exits, including Srinivas Narayanan, as leaders and researchers depart amid a ...
SINGAPORE, SINGAPORE, SINGAPORE, April 17, 2026 /EINPresswire.com/ -- Singapore, April 17, 2026 – In 2026, enterprises ...
OpenAI has expanded the capabilities of its agent-building toolkit, as agentic AI continues to grow in popularity.
Srinivas Narayanan, the CTO of OpenAI's B2B Applications, has announced his decision to resign from the company next week.
OpenAI’s updated Agents SDK adds sandboxing, configurable memory, and file/tool workflows for safer, stronger enterprise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results